248 related articles for article (PubMed ID: 29859097)
1. Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime.
Moll S; Yasui Y; Abed A; Murata T; Shimada H; Maeda A; Fukushima N; Kanamori M; Uhles S; Badi L; Cagarelli T; Formentini I; Drawnel F; Georges G; Bergauer T; Gasser R; Bonfil RD; Fridman R; Richter H; Funk J; Moeller MJ; Chatziantoniou C; Prunotto M
J Transl Med; 2018 Jun; 16(1):148. PubMed ID: 29859097
[TBL] [Abstract][Full Text] [Related]
2. Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis.
Kerroch M; Guerrot D; Vandermeersch S; Placier S; Mesnard L; Jouanneau C; Rondeau E; Ronco P; Boffa JJ; Chatziantoniou C; Dussaule JC
FASEB J; 2012 Oct; 26(10):4079-91. PubMed ID: 22751008
[TBL] [Abstract][Full Text] [Related]
3. DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome.
Richter H; Satz AL; Bedoucha M; Buettelmann B; Petersen AC; Harmeier A; Hermosilla R; Hochstrasser R; Burger D; Gsell B; Gasser R; Huber S; Hug MN; Kocer B; Kuhn B; Ritter M; Rudolph MG; Weibel F; Molina-David J; Kim JJ; Santos JV; Stihle M; Georges GJ; Bonfil RD; Fridman R; Uhles S; Moll S; Faul C; Fornoni A; Prunotto M
ACS Chem Biol; 2019 Jan; 14(1):37-49. PubMed ID: 30452219
[TBL] [Abstract][Full Text] [Related]
4. DDR1 role in fibrosis and its pharmacological targeting.
Moll S; Desmoulière A; Moeller MJ; Pache JC; Badi L; Arcadu F; Richter H; Satz A; Uhles S; Cavalli A; Drawnel F; Scapozza L; Prunotto M
Biochim Biophys Acta Mol Cell Res; 2019 Nov; 1866(11):118474. PubMed ID: 30954571
[TBL] [Abstract][Full Text] [Related]
5. DDR1: A major player in renal diseases.
Dorison A; Chantziantoniou C
Cell Adh Migr; 2018; 12(4):299-304. PubMed ID: 29455614
[TBL] [Abstract][Full Text] [Related]
6. Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome.
Kim JJ; David JM; Wilbon SS; Santos JV; Patel DM; Ahmad A; Mitrofanova A; Liu X; Mallela SK; Ducasa GM; Ge M; Sloan AJ; Al-Ali H; Boulina M; Mendez AJ; Contreras GN; Prunotto M; Sohail A; Fridman R; Miner JH; Merscher S; Fornoni A
EBioMedicine; 2021 Jan; 63():103162. PubMed ID: 33340991
[TBL] [Abstract][Full Text] [Related]
7. A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present).
Guo J; Zhang Z; Ding K
Expert Opin Ther Pat; 2020 May; 30(5):341-350. PubMed ID: 32077340
[No Abstract] [Full Text] [Related]
8. Novel therapeutic perspectives for crescentic glomerulonephritis through targeting parietal epithelial cell activation and proliferation.
Huang Y; Zhao X; Zhang Q; Yang X; Hou G; Peng C; Jia M; Zhou L; Yamamoto T; Zheng J
Expert Opin Ther Targets; 2023 Jan; 27(1):55-69. PubMed ID: 36738160
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of EP300 and DDR1 synergistically alleviates pulmonary fibrosis in vitro and in vivo.
Tao J; Zhang M; Wen Z; Wang B; Zhang L; Ou Y; Tang X; Yu X; Jiang Q
Biomed Pharmacother; 2018 Oct; 106():1727-1733. PubMed ID: 30119248
[TBL] [Abstract][Full Text] [Related]
10. Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis.
Borza CM; Su Y; Tran TL; Yu L; Steyns N; Temple KJ; Skwark MJ; Meiler J; Lindsley CW; Hicks BR; Leitinger B; Zent R; Pozzi A
Matrix Biol; 2017 Jan; 57-58():258-271. PubMed ID: 27915093
[TBL] [Abstract][Full Text] [Related]
11. Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease.
Gross O; Girgert R; Beirowski B; Kretzler M; Kang HG; Kruegel J; Miosge N; Busse AC; Segerer S; Vogel WF; Müller GA; Weber M
Matrix Biol; 2010 Jun; 29(5):346-56. PubMed ID: 20307660
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of genetic inhibition of Discoidin Domain Receptor 1 in experimental renal disease.
Kerroch M; Alfieri C; Dorison A; Boffa JJ; Chatziantoniou C; Dussaule JC
Sci Rep; 2016 Feb; 6():21262. PubMed ID: 26880216
[TBL] [Abstract][Full Text] [Related]
13. The Role of Discoidin Domain Receptor 1 in Inflammation, Fibrosis and Renal Disease.
Dorison A; Dussaule JC; Chatziantoniou C
Nephron; 2017; 137(3):212-220. PubMed ID: 28743124
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model.
Bansod S; Saifi MA; Godugu C
Sci Rep; 2021 Jun; 11(1):12894. PubMed ID: 34145346
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor α.
Dai Y; Chen A; Liu R; Gu L; Sharma S; Cai W; Salem F; Salant DJ; Pippin JW; Shankland SJ; Moeller MJ; Ghyselinck NB; Ding X; Chuang PY; Lee K; He JC
Kidney Int; 2017 Dec; 92(6):1444-1457. PubMed ID: 28756872
[TBL] [Abstract][Full Text] [Related]
16. Role of integrin-linked kinase in epithelial-mesenchymal transition in crescent formation of experimental glomerulonephritis.
Shimizu M; Kondo S; Urushihara M; Takamatsu M; Kanemoto K; Nagata M; Kagami S
Nephrol Dial Transplant; 2006 Sep; 21(9):2380-90. PubMed ID: 16728424
[TBL] [Abstract][Full Text] [Related]
17. Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond.
Ma TK; McAdoo SP; Tam FW
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i129-i138. PubMed ID: 28391340
[TBL] [Abstract][Full Text] [Related]
18. The Extracellular Matrix Receptor Discoidin Domain Receptor 1 Regulates Collagen Transcription by Translocating to the Nucleus.
Chiusa M; Hu W; Liao HJ; Su Y; Borza CM; de Caestecker MP; Skrypnyk NI; Fogo AB; Pedchenko V; Li X; Zhang MZ; Hudson BG; Basak T; Vanacore RM; Zent R; Pozzi A
J Am Soc Nephrol; 2019 Sep; 30(9):1605-1624. PubMed ID: 31383731
[TBL] [Abstract][Full Text] [Related]
19. Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma.
Hur H; Ham IH; Lee D; Jin H; Aguilera KY; Oh HJ; Han SU; Kwon JE; Kim YB; Ding K; Brekken RA
BMC Cancer; 2017 Jan; 17(1):87. PubMed ID: 28143619
[TBL] [Abstract][Full Text] [Related]
20. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells.
Song J; Chen X; Bai J; Liu Q; Li H; Xie J; Jing H; Zheng J
Tumour Biol; 2016 Aug; 37(8):11509-21. PubMed ID: 27020590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
